Medicare Enrolled

Dr. Aaron Fischman, M.D.

Radiation Oncology · New York, NY
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Consulting-driven
1176 5TH AVE, New York, NY 10029
2122417409
In practice since 2008 (18 years)
NPI: 1699934844 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Fischman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Fischman? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Fischman

Dr. Aaron Fischman is a radiation oncology specialist in New York, NY, with 18 years of NPI registration. Based on federal Medicare data, Dr. Fischman performed 11,118 Medicare services across 500 unique beneficiaries.

Between the years covered by Open Payments, Dr. Fischman received a total of $202,519 from 26 pharmaceutical and/or device companies across 276 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in radiation oncology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Fischman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice ▲ Top 15% volume in NY $202,519 industry payments

Medicare Practice Summary

Medicare Utilization ↗
11,118
Medicare services
Top 15% in NY for radiation oncology
500
Unique beneficiaries
$9
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~618 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Contrast dye for imaging (iodine-based)
A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures.
10,547 $0 $1
Arterial catheter insertion, initial third order branch
Insertion of a tube into an abdominal, pelvic, or leg artery, specifically targeting the initial third order branch.
148 $141 $8,625
Arterial tube insertion, additional vessels
This code covers the insertion of a tube into an additional artery in the abdomen, pelvis, or leg during a procedure where other arteries have already been accessed.
136 $43 $403
Vessel or growth occlusion with radiologist review
A procedure to block blood flow to growths or obstructed vessels, including review by a radiologist.
70 $502 $40,250
CT scan of pelvic blood vessels with contrast
A CT scan that uses contrast dye to create detailed images of the blood vessels in the pelvis.
37 $218 $893
CT scan of chest blood vessels with contrast
A CT scan that uses contrast dye to create detailed images of the blood vessels in the chest.
36 $202 $1,260
CT scan of abdominal and pelvic blood vessels with contrast
A computed tomography scan that uses contrast dye to visualize the blood vessels in the abdomen and pelvis.
32 $377 $2,036
Sedation by physician, initial 15 minutes
Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older.
27 $48 $125
Additional sedation, per 15 minutes
Administration of a drug to deepen sedation during a procedure. This code covers each additional 15-minute increment of sedation beyond the initial period.
26 $11 $40
Radiologist review of CT-guided needle placement
A radiologist reviews the CT imaging used to guide the placement of a needle.
13 $61 $656
Fluoroscopic guidance for central vein access device
Use of live X-ray imaging to guide the placement or removal of a central vein access device.
12 $91 $338
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
12 $154 $375
CT scan of abdominal aorta and leg arteries with contrast
A CT scan that uses contrast dye to create detailed images of the abdominal aorta and the arteries in both legs.
11 $273 $1,575
Ultrasound guidance for blood vessel access
Use of ultrasound imaging to help locate and access a blood vessel. This guidance assists healthcare providers in performing procedures such as inserting IV lines or drawing blood.
11 $38 $132
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.3% high complexity
96.0% medium
2.7% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$202,519
Total received (2018-2024)
Avg $28,931/year across 7 years
Top 2% in NY for radiation oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
26
Companies
276
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$166,213 (82.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$34,398 (17.0%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,907 (0.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$35,542
2023
$28,753
2022
$56,087
2021
$25,946
2020
$10,566
2019
$21,359
2018
$24,265

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Boston Scientific Corporation
$16,499
Terumo Medical Corporation
$8,316
GUERBET LLC
$5,400
Siemens Medical Solutions USA, Inc.
$4,000
Medical Device Business Services, Inc.
$1,200
Recor Medical Inc
$108
Instylla, Inc.
$18
Top 3 companies account for 85.0% of 2024 payments
All-time payments by company (2018-2024) ›
Terumo Medical Corporation
$71,181
Boston Scientific Corporation
$49,033
Embolx, Inc.
$41,200
BOSTON SCIENTIFIC CORPORATION
$14,089
Biocompatibles, Inc.
$7,999
Siemens Medical Solutions USA, Inc.
$6,480
GUERBET LLC
$6,144
Medical Device Business Services, Inc.
$3,278
BTG International, Inc.
$500
Okami Medical, Inc.
$450
Bard Access Systems, Inc.
$308
ARGON MEDICAL DEVICES, INC.
$241
Cardinal Health 200, LLC
$204
Imperative Care, Inc
$199
Medtronic USA, Inc.
$198
Ethicon US, LLC
$163
Penumbra, Inc.
$150
Sirtex Medical Inc
$150
TriSalus Life Sciences, Inc.
$146
Recor Medical Inc
$108
Surefire Medical, Inc.
$76
Medtronic Vascular, Inc.
$58
Abbott Laboratories
$58
Ethicon Endo-Surgery Inc.
$50
AngioDynamics, Inc.
$38
Instylla, Inc.
$18
Top 3 companies account for 79.7% of all-time payments
Associated products mentioned in payments ›
ALPHAVAC · ANGIOJET · AZUR · AZUR CX DETACHABLE · Azur CX Detachable · CERTUS 140 MICROWAVE ABLATION SYSTEM · CLEANER · DIREXION · EKOSONIC · ELUVIA · EMBOGUARD · EMBOLD Fibered · EMBOZENE · Embolization Spheres · FATHOM · GENERAL THERAPIES · GENERAL ANGIOGRAPHY · GENERAL THERAPIES · GENERAL VASCULAR INTERVENTION · GENERAL - IO ABLATION · GENERAL - THERAPIES · GENERAL - VASCULAR INTERVENTION · GENERAL ANGIOGRAPHY · GENERAL ATHERECTOMY · GENERAL CATHETERS · GENERAL GUIDEWIRES · GENERAL IO ABLATION · GENERAL PAIN MANAGEMENT · GENERAL THROMBECTOMY · GLIDESHEATH SLENDER · GLIDEWIRE · General - Therapies · General - Vascular Intervention · Glidesheath · HYDROPEARL · INSTYLLA DELIVERY KIT · INTERLOCK · Indigo · KYPHON Balloon Kyphoplasty · LIPIODOL · LOBO · MVP · MynxGrip Vascular Closure Device · NAVICROSS · NEUWAVE Flex Microwave Ablation System · Navicross · Neuwave · OPTION · OUTBACK LTD Re-Entry Catheter · PARADISE RENAL DENERVATION SYSTEM · POD · PRODIGY CATHETER · SENTRY · SEQURE · SIR-Spheres Microspheres · SKATER · Supera peripheral stent system · Surefire Infusion Systems · THERAPIES · THERASPHERE · THERASPHERE - BIO · THERASPHERE-BIO · TLAB · TR BAND · TR Band · TRINAV INFUSION SYSTEM · TheraSphere · TheraSphere Y90 Glass Microspheres 10 GBq · TheraSphere Y90 Glass Microspheres 7.0 GBq (US Commercial) · Watchman
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (82%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 2% for radiation oncology in NY.

Looking for a radiation oncology specialist in New York?
Compare radiation oncologists in the New York area by procedure volume, costs, and industry payment transparency.
Browse radiation oncologists nearby

Geographic Context

Radiation oncologists within 10 mi
2,044
Per 100K population
125.6
County median income
$104,553
Nearest hospital
MOUNT SINAI HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Fischman is a mixed practice specialist, with above-average Medicare volume (top 15% in NY), with consulting-driven industry engagement in the top 2% of NY peers, with 18 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Fischman experienced with contrast dye for imaging (iodine-based)?
Based on Medicare claims data, Dr. Fischman performed 10,547 contrast dye for imaging (iodine-based) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Fischman receive payments from pharmaceutical companies?
Yes. Dr. Fischman received a total of $202,519 from 26 companies across 276 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Fischman's costs compare to other radiation oncologists in New York?
Dr. Fischman's average Medicare payment per service is $9. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Fischman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →